tiprankstipranks
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market
Holding VYNE?
Track your performance easily

VYNE Therapeutics (VYNE) Technical Analysis

1,823 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
4Neutral
10Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
VYNE Therapeutics’s (VYNE) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting VYNE Therapeutics is a Buy.
VYNE Therapeutics’s (VYNE) 20-Day exponential moving average is 3.05, while VYNE Therapeutics’s (VYNE) share price is $2.7, making it a Sell.
VYNE Therapeutics’s (VYNE) 50-Day exponential moving average is 2.89, while VYNE Therapeutics’s (VYNE) share price is $2.7, making it a Sell.

VYNE Therapeutics (VYNE) Pivot Points

Jan 18, 2025, 05:55 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.16
2.37
2.47
2.68
2.78
2.99
3.09
Fibonacci
2.37
2.49
2.56
2.68
2.80
2.87
2.99
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

VYNE Therapeutics (VYNE) Moving Averages

Jan 18, 2025, 05:55 PM
Period
Simple
Exponential
MA5
2.76Sell
2.84Sell
MA10
3.29Sell
3.02Sell
MA20
3.10Sell
3.05Sell
MA50
2.94Sell
2.89Sell
MA100
2.50Buy
2.66Buy
MA200
2.38Buy
2.49Buy
VYNE Therapeutics’s (VYNE) 10-Day exponential moving average is 3.02, while VYNE Therapeutics’s (VYNE) share price is $2.7, making it a Sell.
VYNE Therapeutics’s (VYNE) 100-Day exponential moving average is 2.66, while VYNE Therapeutics’s (VYNE) share price is $2.7, making it a Buy.
VYNE Therapeutics’s (VYNE) stock price is $2.7 and VYNE Therapeutics’s (VYNE) 50-day simple moving average is 2.94, creating a Sell signal.
VYNE Therapeutics’s (VYNE) stock price is $2.7 and VYNE Therapeutics’s (VYNE) 100-day simple moving average is 2.50, creating a Buy signal.
VYNE Therapeutics’s (VYNE) stock price is $2.7 and VYNE Therapeutics’s (VYNE) 200-day simple moving average is 2.38, creating a Buy signal.

VYNE Therapeutics (VYNE) Technical Indicators

Jan 18, 2025, 05:55 PM
Name
Value
Implied Action
RSI (14)
43.45
Neutral
STOCH (9,6)
4.73
Buy
STOCHRSI (14)
7.03
Buy
MACD (12,26)
0.02
Buy
ADX (14)
27.68
Neutral
Williams %R
-92.49
Buy
CCI (14)
-57.38
Neutral
ATR (14)
0.35
-
Ultimate Oscillator
32.44
Neutral
ROC
-16.41
Sell
VYNE Therapeutics’s (VYNE) Relative Strength Index (RSI) is 43.45, creating a Neutral signal.
VYNE Therapeutics’s (VYNE) Trend Strength Indicator (ADX) is 27.68, creating a Neutral signal.
VYNE Therapeutics’s (VYNE) Commodity Channel Index (CCI) is -57.38, creating a Neutral signal.
VYNE Therapeutics’s (VYNE) Price Rate of Change (ROC) is -16.41, creating a Sell signal.

FAQ

Is VYNE a Buy, Hold, or Sell?
Based on VYNE’s technical indicators, VYNE is a Hold.
    What is VYNE’s RSI (14)?
    VYNE’s RSI (14) is 43.45, which suggests VYNE is a Neutral.
      What is VYNE’s MACD?
      VYNE’s MACD is 0.02, which suggests VYNE is a Buy.
        What is VYNE’s 5-day moving average?
        VYNE’s 5-day moving average is 2.76, which suggests VYNE is a Sell.
          What is VYNE’s 20-day moving average?
          VYNE 20-day moving average is 3.10, which suggests VYNE is a Sell.
            What is VYNE’s 50-day moving average?
            VYNE’s 50-day moving average is 2.94, which suggests VYNE is a Sell.
              What is VYNE’s 200-day moving average?
              VYNE’s 200-day moving average is 2.38, which suggests VYNE is a Buy.
                What is VYNE’s Williams % R (14)?
                VYNE’s Williams % R (14) is -92.49, which suggests VYNE is a Buy.
                  What is VYNE’s CCI (14)?
                  VYNE’s CCI (14) is -57.38, which suggests VYNE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis